The role of intramuscular lipid in insulin resistance

Acta Physiologica Scandinavica

Volumn 178, Issue 4, 2003, Pages 373-383

  Hegarty, B D ^a   Furler, S M ^a   Ye, J ^a   Cooney, G J ^a   Kraegen, Edward W ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Acyl CoAs; Ceramide; Diacylglycerol; Dietary fat; Fatty acid tracers; In vivo insulin action; Muscle; Protein kinase C

Indexed keywords

ACYL COENZYME A; CERAMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL; FATTY ACID; GLUCOSE; GLYCOGEN SYNTHASE; HEXOKINASE; HEXOSAMINE; INSULIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROTEIN KINASE C;

BIOACCUMULATION; CONFERENCE PAPER; CYTOSOL; FAT INTAKE; FATTY ACID TRANSPORT; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; MUSCLE LEVEL; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL;

ACYL COENZYME A; ANIMALS; CERAMIDES; CYTOSOL; DIETARY FATS; DIGLYCERIDES; GLUCOSE; HEXOSAMINES; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MODELS, BIOLOGICAL; MUSCLES; PROTEIN KINASE C;

EID: 0042160182     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.2003.01162.x     Document Type: Conference Paper

References (121)

1. Atkinson, L.L., Fischer, M.A. & Lopaschuk, G.D. 2002. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J Biol Chem 277, 29424-29430.
2. Bachmann, O.P., Dahl do, M.B., Brechtel, K. et al. 2001. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50, 2579-2584.
3. Basu, A., Basu, R., Shah, P., Vella, A., Rizza, R.A. & Jensen, M.D. 2001. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 280, E1000-E1006.
4. Bell, K.S., Schmitz-Peiffer, C., Lim-Fraser, M., Biden, T.J., Cooney, G.J. & Kraegen, E.W. 2000. Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-theta localization. Am J Physiol Endocrinol Metab 279, E1196-E1201.
5. Berg, A.H., Combs, T.P., Du, X., Brownlee, M. & Scherer, P.E. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7, 947-953.
6. Bjornholm, M., Kawano, Y., Lehtihet, M. & Zierath, J.R. 1997. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46, 524-527.
7. Blaak, E.E., Wagenmakers, A.J., Glatz, J.F. et al. 2000. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279, E146-E154.
8. Boden, G., Jadali, F., White, J. et al. 1991. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88, 960-966.
9. Boden, G., Chen, X., Ruiz, J., White, J.V. & Rossetti, L. 1994. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93, 2438-2446.
10. Boden, G., Lebed, B., Schatz, M., Homko, C. & Lemieux, S. 2001. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50, 1612-1617.
11. Cazzolli, R., Carpenter, L., Biden, T.J. & Schmitz-Peiffer, C. 2001. A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes 50, 2210-2218.
12. Chalkley, S.M., Hettiarachchi, M., Chisholm, D.J. & Kraegen, E.W. 1998. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47, 1121-1126.
13. Chen, M.T., Kaufman, L.N., Spennetta, T. & Shrago, E. 1992. Effects of high fat-feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme A esters in liver and skeletal muscle. Metabolism 41, 564-569.
14. Choi, C.S., Lee, F.N. & Youn, J.H. 2001. Free fatty acids induce peripheral insulin resistance without increasing muscle hexosamine pathway product levels in rats. Diabetes 50, 418-424.
15. Colberg, S.R., Simoneau, J.A., Thaete, F.L. & Kelley, D.E. 1995. Skeletal muscle utilization of free fatty acids in women with visceral obesity (see comments). J Clin Invest 95, 1846-1853.
16. Corkey, B.E., Deeney, J.T., Yaney, G.C., Tornheim, K. & Prentki, M. 2000. The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. J Nutr 130, 299S-304S.
17. Cortright, R.N., Azevedo, J.L. Jr., Zhou, Q. et al. 2000. Protein kinase C modulates insulin action in human skeletal muscle. Am J Physiol Endocrinol Metab 278, E553-E562.
18. Cutler, R.G. & Mattson, M.P. 2001. Sphingomyelin and ceramide as regulators of development and lifespan. Mech Ageing Dev 122, 895-908.
19. DeFronzo, R.A., Jacot, E., Jequier, E., Maeder, E., Wahren, J. & Felber, J.P. 1981. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000-1007.
20. DiRusso, C.C., Heimert, T.L. & Metzger, A.K. 1992. Characterization of FadR, a global transcriptional regulator of fatty acid metabolism in Escherichia coli. Interaction with the fadB promoter is prevented by long chain fatty acyl coenzyme A. J Biol Chem 267, 8685-8691.
21. Dobbins, R.L., Szczepaniak, L.S., Bentley, B., Esser, V., Myhili, J. & McGarry, J.D. 2001. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50, 123-130.
22. Dresner, A., Laurent, D., Marcucci, M. et al. 1999. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103, 253-259.
23. Ellis, B.A., Poynten, A., Lowy, A.J. et al. 2000. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279, E554-E560.
24. Enoksson, S., Degerman, E., Hagstrom-Toft, E., Large, V. & Arner, P. 1998. Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man. Diabetologia 41, 560-568.
25. Faergeman, N.J. & Knudsen, J. 1997. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem J 323, 1-12.
26. Ferrannini, E. 1988. The theoretical bases of indirect calorimetry: a review. Metabolism 37, 287-301.
27. Ferrannini, E., Barrett, E.J., Bevilacqua, S. & DeFronzo, R.A. 1983. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72, 1737-1747.
28. Friedman, J.E., Dohm, G.L., Leggett-Frazier, N. et al. 1992. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest 89, 701-705.
29. Fruebis, J., Tsao, T.S., Javorschi, S. et al. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98, 2005-2010.
30. Furler, S.M., Cooney, G.J., Hegarty, B.D., Lim-Fraser, M.Y., Kraegen, E.W. & Oakes, N.D. 2000. Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. Diabetes 49, 1427-1433.
31. Furler, S.M., Lapsys, N., Denyer, G.S. et al. 2002. Selective reversal of high fat diet induced muscle gene expression by PPAR agonists: micoarray analysis in rats. Diabetologia 45 (Suppl. 2), A238.
32. Gan, S.K., Kraegen, E.W., Carr, A., Thompson, C.H. et al. 2002. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes 451, 3163-3169.
33. Garvey, W.T., Maianu, L., Hancock, J.A., Golichowski, A.M. & Baron, A. 1992. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41, 465-475.
34. Goodpaster, B.H., Thaete, F.L., Simoneau, J.A. & Kelley, D.E. 1997. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46, 1579-1585.
35. Goodpaster, B.H., Thaete, F.L. & Kelley, D.E. 2000. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 71, 885-892.
36. Goodyear, L.J., Giorgino, F., Sherman, L.A., Carey, J., Smith, R.J. & Dohm, G.L. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95, 2195-2204.
37. Griffin, M.E., Marcucci, M.J., Cline, G.W. et al. 1999. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48, 1270-1274.
38. Guerre-Millo, M., Gervois, P., Raspe, E. et al. 2000. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275, 16638-16642.
39. Hajduch, E., Balendran, A., Batty, I.H. et al. 2001. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44, 173-183.
40. Halaas, J.L., Gajiwala, K.S., Maffei, M. et al. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
41. Hawkins, M., Barzilai, N., Liu, R., Hu, M., Chen, W. & Rossetti, L. 1997. Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99, 2173-2182.
42. Hegarty, B.D., Cooney, G.J., Kraegen, E.W. & Furler, S.M. 2002. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51, 1477-1484.
43. Hertz, R., Magenheim, J., Berman, I. & Bar-Tana, J. 1998. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392, 512-516.
44. Hotamisligil, G.S. 1999. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245, 621-625.
45. Hundal, R.S., Petersen, K.F., Mayerson, A.B. et al. 2002. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109, 1321-1326.
46. Ido, Y., Carling, D. & Ruderman, N. 2002. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells - inhibition by the AMP-activated protein kinase activation. Diabetes 51, 159-167.
47. Iglesias, M.A., Ye, J.M., Frangioudakis, G. et al. 2002. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin resistant high-fat fed rats. Diabetes 451, 2886-2894.
48. Itani, S.I., Ruderman, N.B., Schmieder, F. & Boden, G. 2002. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C and IkB-alpha. Diabetes 51, 2005-2011.
49. Jensen, M.D. 1997. Lipolysis: contribution from regional fat. Annu Rev Nutr 17, 127-139.
50. Kanety, H., Hemi, R., Papa, M.Z. & Karasik, A. 1996. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 271, 9895-9897.
51. Kelley, D.E. & Mandarino, L.J. 2000. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49, 677-683.
52. Kelley, D.E., Mokan, M., Simoneau, J.A. & Mandarino, L.J. 1993. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92, 91-98.
53. Kelley, D.E., Goodpaster, B., Wing, R.R. & Simoneau, J.A. 1999. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277, E1130-E1141.
54. Kelley, D.E. & Simoneau, J.A. 1994. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94, 2349-2356.
55. Kim, J.K., Wi, J.K. & Youn, J.H. 1996. Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats. Diabetes 45, 651-658.
56. Kim, Y.B., Nikoulina, S.E., Ciaraldi, T.P., Henry, R.R. & Kahn, B.B. 1999. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104, 733-741.
57. Kim, J.K., Gavrilova, O., Chen, Y., Reitman, M.L. & Shulman, G.I. 2000. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275, 8456-8460.
58. Kim, J.K., Fillmore, J.J., Chen, Y. et al. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 98, 7522-7527.
59. Knuuti, J., Takala, T.O., Nagren, K. et al. 2001. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia 44, 184-187.
60. Koya, D. & King, G.L. 1998. Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859-866.
61. Koyama, K., Chen, G., Lee, Y. & Unger, R.H. 1997. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 273, E708-E713.
62. Kraegen, E.W., Clark, P.W., Jenkins, A.B., Daley, E.A., Chisholm, D.J. & Storlien, L.H. 1991. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40, 1397-1403.
63. Krssak, M., Falk Petersen, K., Dresner, A. et al. 1999. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study (published errata appeared in Diabetologia 1999; 42, 386 and 1999; 42, 1269). Diabetologia 42, 113-116.
64. Laybutt, D.R., Chisholm, D.J. & Kraegen, E.W. 1997. Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats. Am J Physiol 273, E1-E9.
65. Laybutt, D.R., Schmitz-Peiffer, C., Saha, A.K., Ruderman, N.B., Biden, T.J. & Kraegen, E.W. 1999. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat. Am J Physiol 277, E1070-E1076.
66. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M. & Kliewer, S.A. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270, 12953-12956.
67. Maki, M.T., Haaparanta, M., Nuutila, P. et al. 1998. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid. J Nucl Med 39, 1320-1327.
68. Martin, G., Schoonjans, K., Staels, B. & Auwerx, J. 1998. PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis 137 (Suppl), S75-S80.
69. Mensink, M., Blaak, E.E., van Baak, M.A., Wagenmakers, A.J. & Saris, W.H. 2001. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50, 2548-2554.
70. Minokoshi, Y., Kim, Y.B., Peroni, O.D. et al. 2002. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343.
71. Muoio, D.M., Dohm, G.L., Fiedorek, F.T. Jr., Tapscott, E.B., Coleman, R.A. & Dohm, G.L. 1997. Leptin directly alters lipid partitioning in skeletal muscle (published erratum appears in Diabetes 1997;46, 1663). Diabetes 46, 1360-1363.
72. Nesher, M. & Boneh, A. 1994. Effect of fatty acids and their acyl-CoA esters on protein kinase C activity in fibroblasts: possible implications in fatty acid oxidation defects. Biochim Biophys Acta 1221, 66-72.
73. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9, 484-496.
74. Oakes, N.D., Kennedy, C.J., Jenkins, A.B., Laybutt, D.R., Chisholm, D.J. & Kraegen, E.W. 1994. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43, 1203-1210.
75. Oakes, N.D., Bell, K.S., Furler, S.M. et al. 1997a. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes 46, 2022-2028.
76. Oakes, N.D., Camilieri, S., Furler, S.M., Chisholm, D.J. & Kraegen, E.W. 1997b. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism 46, 935-942.
77. Oakes, N.D., Cooney, G.J., Camilieri, S., Chisholm, D.J. & Kraegen, E.W. 1997c. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46, 1768-1774.
78. Oakes, N.D., Kjellstedt, A., Forsberg, G.B. et al. 1999. Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer. J Lipid Res 40, 1155-1169.
79. Oakes, N.D., Thalen, P.G., Jacinto, S.M. & Ljung, B. 2001. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes 50, 1158-1165.
80. Orellana, A., Hidalgo, P.C., Morales, M.N., Mezzano, D. & Bronfman, M. 1990. Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme. Eur J Biochem 190, 57-61.
81. Pan, D.A., Lillioja, S., Kriketos, A.D. et al. 1997. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46, 983-988.
82. Paolisso, G. & Howard, B.V. 1998. Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus (see comments). Diabet Med 15, 360-366.
83. Pelleymounter, M.A., Cullen, M.J., Baker, M.B. et al. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543.
84. Peraldi, P., Hotamisligil, G.S., Buurman, W.A., White, M.F. & Spiegelman, B.M. 1996. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271, 13018-13022.
85. Perseghin, G., Scifo, P., De Cobelli, F. et al. 1999. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48, 1600-1606.
86. Phillips, D.I., Caddy, S., Ilic, V. et al. 1996. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45, 947-950.
87. Pravenec, M., Landa, V., Zidek, V. et al. 2001. Transgenic rescue of defective CD36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 27, 156-158.
88. Qu, X., Seale, J.P. & Donnelly, R. 1999. Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding. J Endocrinol 162, 207-214.
89. Raman, N. & DiRusso, C.C. 1995. Analysis of acyl coenzyme A binding to the transcription factor FadR and identification of amino acid residues in the carboxyl terminus required for ligand binding. J Biol Chem 270, 1092-1097.
90. Randle, P.J., Garland, P.B., Hales, C.N. & Newsholm, E.A. 1963. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
91. Randle, P.J., Newsholme, E.A. & Garland, P.B. 1964. Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 93, 652-665.
92. Randle, P.J., Garland, P.B., Newsholme, E.A. & Hales, C.N. 1965. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci 131, 324-333.
93. Reaven, G.M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
94. Roden, M., Price, T.B., Perseghin, G. et al. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97, 2859-2865.
95. Roden, M., Krssak, M., Stingi, H. et al. 1999. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48, 358-364.
96. Rossetti, L. 2000. Perspective: hexosamines and nutrient sensing. Endocrinology 141, 1922-1925.
97. Rottman, J.N., Bracy, D., Malabanan, C., Yue, Z., Clanton, J. & Wasserman, D.H. 2002. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am J Physiol 283, E116-E123.
98. Schmitz-Peiffer, C. 2000. Signalling aspects of insulin resistance in skeletal muscle. Mechanisms induced by lipid over-supply. Cell Signal 12, 583-594.
99. Schmitz-Peiffer, C., Browne, C.L., Oakes, N.D. et al. 1997a. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46, 169-178.
100. Schmitz-Peiffer, C., Oakes, N.D., Browne, C.L., Kraegen, E.W. & Biden, T.J. 1997b. Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. Am J Physiol 273, E915-E921.
101. Schmitz-Peiffer, C., Craig, D.L. & Biden, T.J. 1999. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274, 24202-24210.
102. Shafrir, E. & Ziv, E. 1998. Cellular mechanism of nutritionally induced insulin resistance: the desert rodent Psammomys obesus and other animals in which insulin resistance leads to detrimental outcome. J Basic Clin Physiol Pharmacol 9, 347-385.
103. Shimabukuro, M., Koyama, K., Chen, G. et al. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94, 4637-4641.
104. Shimomura, I., Hammer, R.E., Ikemoto, S., Brown, M.S. & Goldstein, J.L. 1999. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401, 73-76.
105. Staels, B., Schoonjans, K., Fruchart, J.C. & Auwerx, J. 1997. The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs). Biochimie 79, 95-99.
106. Steppan, C.M., Bailey, S.T., Bhat, S. et al. 2001. The hormone resistin links obesity to diabetes. Nature 409, 307-312.
107. Storlien, L.H., Jenkins, A.B., Chisholm, D.J., Pascoe, W.S., Khouri, S. & Kraegen, E.W. 1991. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40, 280-289.
108. Summers, S.A., Garza, L.A., Zhou, H. & Birnbaum, M.J. 1998. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18, 5457-5464.
109. Swinburn, B.A., Metcalf, P.A. & Ley, S.J. 2001. Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabet Care 24, 619-624.
110. Szczepaniak, L.S., Babcock, E.E., Schick, F. et al. 1999. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276, E977-E989.
111. Thompson, A.L. & Cooney, G.J. 2000. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes 49, 1761-1765.
112. Thompson, A.L., Lim-Fraser, M.Y., Kraegen, E.W. & Cooney, G.J. 2000. Effects of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro. Am J Physiol Endocrinol Metab 279, E577-E584.
113. Turinsky, J., O'Sullivan, D.M. & Bayly, B.P. 1990. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 265, 16880-16885.
114. Turpeinen, A.K., Takala, T.O., Nuutila, P. et al. 1999. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R, S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes 48, 1245-1250.
115. Virkamaki, A., Korsheninnikova, E., Seppala-Lindroos, A. et al. 2001. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 50, 2337-2343.
116. WHO. 1997. Obesity: Preventing and Managing the Global Epidemic-Report of a WHO Consultation on Obesity. WHO, Geneva.
117. Wolfe, R.R. 1992. Radioactive and Stable Isotope Tracers in Biomedicine. Principles and Practice of Kinetic Analysis. Wiley-Liss, Inc., New York.
118. Yamauchi, T., Kamon, J., Waki, H. et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941-946.
119. Yaney, G.C., Korchak, H.M. & Corkey, B.E. 2000. Long-chain acyl CoA regulation of protein kinase C and fatty acid potentiation of glucose-stimulated insulin secretion in clonal beta-cells. Endocrinology 141, 1989-1998.
120. Ye, J.M., Doyle, P.J., Iglesias, M.A., Watson, D.G., Cooney, G.J. & Kraegen, E.W. 2001. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 50, 411-417.
121. Yu, C., Chen, Y., Cline, G.W. et al. 2002. Mechanism by which fatty acids inhibit insulin activation of IRS-1 associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277, 50230-50236.